Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.34
-0.64 (-1.88%)
Jul 31, 2026, 4:08 PM HKT

HKG:1501 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,0651,065851.95752.84585.88464.68
Revenue Growth
15.72%25.06%13.17%28.50%26.08%29.64%
Gross Profit
636.79636.79537.66438.07332.49275.75
Operating Income
258.29258.29212.02161.99129.34144.64
Net Income
206.23206.23180.92151.88130.15142.96
Earnings Per Share
1.261.261.100.920.780.86
EPS Growth
15.25%14.17%20.10%17.49%-9.38%17.81%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Elimination of Inter-Segment
-115.63-115.63-83.55-48.73-44.43-28.24
ALL Others
304.17304.17163.57160.24133.2681.73
Cardiovascular Interventional Business
876.93876.93771.93641.32497.05411.18
Total
1,0651,065851.95752.84585.88464.68

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
650.81650.81551.95434.4528.27640.55
Total Debt
715.96715.96243.6994.7848.8313.4
Net Cash (Debt)
-65.14-65.14308.27339.62479.44627.15
Net Cash Growth
---9.23%-29.16%-23.55%-33.27%
Net Cash Per Share
-0.38-0.381.811.992.843.76

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
348.11348.11225.54178.15180.4672.76
Capital Expenditures
-64.48-64.48-125.74-168.84-243.21-277.83
Free Cash Flow
283.63283.6399.89.31-62.75-205.07
Free Cash Flow Growth
94.16%184.18%972.35%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
59.77%59.77%63.11%58.19%56.75%59.34%
Operating Margin
24.24%24.24%24.89%21.52%22.08%31.13%
Pretax Margin
24.24%24.24%25.05%23.26%24.66%33.51%
Profit Margin
19.36%19.36%21.24%20.18%22.21%30.77%
FCF Margin
26.62%26.62%11.71%1.24%-10.71%-44.13%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.2600.230-0.2700.2400.260
Dividend Per Share Growth
0%--12.50%-7.69%-8.77%
Dividend Yield
0.78%0.86%-1.06%0.97%1.46%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
23.8622.8926.4729.2332.8321.76
Forward PE
-23.0318.8820.4420.8923.81
P/FCF Ratio
22.1216.6447.97476.97--
PS Ratio
5.894.435.625.907.296.69